LetsGetChecked is moving into genomics with the acquisition of the genetic testing technology provider, allowing Lilly Ventures Asia and Jiangsu Simcere to exit.
At-home diagnostic test provider LetsGetChecked agreed to acquire US-based genetic testing technology developer Veritas Genetics on Tuesday for an undisclosed sum, providing exits for pharmaceutical firms Eli Lilly and Jiangsu Simcere Pharmaceutical. Spun out of Harvard University in 2014, Veritas offer sgenome and exome based genetic tests used to detect hereditary illnesses such as cancer…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
